At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
13C urea breath test Kitdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Detection of Pseudomonas. Aeruginosa in the Airways of Patients With Cystic Fibrosis Using of Aerosolized 13C-urea
In Brief
A clinical study evaluating 13C urea breath test Kit for Cystic Fibrosis. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if inhaled urea can be used to detect the presence of Pseudomonas Aeruginosa in the lungs
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2011
Enrollment StartAug 2012
Primary CompletionAug 2014
Study CompletionAug 2015
TodayJul 2026
First PostedFeb 24, 2011
Enrollment StartAug 15, 2012
Primary CompletionAug 1, 2014
Study CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 15.4 years ago
Interventions
13C urea breath test Kitdevice
20 and 50 mg, 13C urea breath test: urea nebulizer solution to detect Pseudomonas